Reported Earnings • Jul 01
Full year 2026 earnings released: HK$0.035 loss per share (vs HK$0.035 loss in FY 2025) Full year 2026 results: HK$0.035 loss per share (in line with FY 2025). Revenue: HK$40.2m (up 146% from FY 2025). Net loss: HK$7.54m (loss widened 1.0% from FY 2025). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 37% per year, which means it is performing significantly worse than earnings. New Risk • Apr 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (HK$31.9m market cap, or US$4.07m). Minor Risk Revenue is less than US$5m (HK$28m revenue, or US$3.6m). Board Change • Jan 01
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairman, CEO & Compliance Officer Liang Huang is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. New Risk • Dec 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (HK$24.8m market cap, or US$3.18m). Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Revenue is less than US$5m (HK$28m revenue, or US$3.6m). Reported Earnings • Nov 28
First half 2026 earnings released: HK$0.016 loss per share (vs HK$0.026 loss in 1H 2025) First half 2026 results: HK$0.016 loss per share (improved from HK$0.026 loss in 1H 2025). Revenue: HK$19.0m (up 161% from 1H 2025). Net loss: HK$3.43m (loss narrowed 38% from 1H 2025). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings. New Risk • Nov 27
New major risk - Revenue and earnings growth Earnings have declined by 23% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Market cap is less than US$10m (HK$29.7m market cap, or US$3.82m). Minor Risk Revenue is less than US$5m (HK$28m revenue, or US$3.6m). Announcement • Nov 11
Hephaestus Holdings Limited to Report First Half, 2026 Results on Nov 26, 2025 Hephaestus Holdings Limited announced that they will report first half, 2026 results on Nov 26, 2025 Board Change • Sep 25
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairman, CEO & Compliance Officer Liang Huang is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Announcement • Aug 04
Hephaestus Holdings Limited, Annual General Meeting, Sep 19, 2025 Hephaestus Holdings Limited, Annual General Meeting, Sep 19, 2025, at 14:30 China Standard Time. Location: 1602, 16/f, park commercial centre, 180 tung lo wan road, causeway bay, Hong Kong Reported Earnings • Aug 02
Full year 2025 earnings released: HK$0.035 loss per share (vs HK$0.04 loss in FY 2024) Full year 2025 results: HK$0.035 loss per share (improved from HK$0.04 loss in FY 2024). Revenue: HK$16.3m (down 42% from FY 2024). Net loss: HK$7.47m (loss narrowed 13% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (HK$32.1m market cap, or US$4.09m). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Revenue is less than US$5m (HK$16m revenue, or US$2.1m). Reported Earnings • Jun 25
Full year 2025 earnings released: HK$0.035 loss per share (vs HK$0.04 loss in FY 2024) Full year 2025 results: HK$0.035 loss per share (improved from HK$0.04 loss in FY 2024). Revenue: HK$16.3m (down 42% from FY 2024). Net loss: HK$7.46m (loss narrowed 13% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 38 percentage points per year, which is a significant difference in performance. Announcement • Jun 10
Hephaestus Holdings Limited to Report Fiscal Year 2025 Results on Jun 24, 2025 Hephaestus Holdings Limited announced that they will report fiscal year 2025 results on Jun 24, 2025 Board Change • May 06
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairman, CEO & Compliance Officer Liang Huang is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. New Risk • Mar 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (HK$29.3m market cap, or US$3.77m). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Revenue is less than US$5m (HK$19m revenue, or US$2.5m). Board Change • Feb 01
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Chairman, CEO & Compliance Officer Liang Huang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Jan 27
Hephaestus Holdings Limited Announces Change of Independent Non-Executive Director and Change in Composition of Board Committees Hephaestus Holdings Limited announced that Mr. Lee Man Chun ("Mr. Lee") has tendered his resignation as an independent non-executive Director due to his other business engagement and ceased to be the chairman of the nomination committee of the Company (the "Nomination Committee") and a member of each of the audit committee of the Company (the "Audit Committee") and the remuneration committee of the Company (the "Remuneration Committee") with effect from 27 January 2025. Mr. Lee has confirmed that he has no disagreement with the Board and there is no other matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company (the "Shareholders"). The Board further announces that with effect from 27 January 2025, Mr. Liu Junda ("Mr. Liu") has been appointed as an independent non-executive Director, the chairman of Nomination Committee, and a member of each of the Audit Committee and the Remuneration Committee. Mr. Liu, aged 36, obtained a degree of Bachelor of Arts in Business Economics from Oxford Brookes University in 2013. Mr. Liu has extensive experience in fund investment and management. Mr. Liu has worked for a number of investment management companies. Mr. Liu currently is the investment director of an assets management company located in China and the executive director of an assets management company located in China. Mr. Liu passed the AMAC (Asset Management Association of China) Fund Practitioner Qualification Examination organized by Asset Management Association of China in 2019. Pursuant to the letter of appointment (the "Letter of Appointment") made between Mr. Liu and the Company, Mr. Liu is appointed as an independent non-executive Director for a term of three years with effect from 27 January 2025, unless terminated by giving to the other party at least one month's notice in writing or as may be agreed between Mr. Liu and the Company. Pursuant to the articles of association of the Company (the "Articles of Association"), Mr. Liu will hold office only until the first annual general meeting of the Company after his appointment and will then be eligible for re-election at that meeting. Further, Mr. Liu will be subject to retirement by rotation and re-election at the annual general meetings of the Company in accordance with the provisions of the Articles of Association. In accordance with the Letter of Appointment, Mr. Liu will be entitled to a Director's fee of HKD 60,000 per annum, which is determined by the Board based on the recommendation of the Remuneration Committee with reference to his background, experience, duties and responsibilities with the Group, and prevailing market conditions and subject to annual review by the Remuneration Committee and the Board. Board Change • Jan 17
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Director Man Chun Lee is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • Dec 25
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Director Man Chun Lee is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. New Risk • Nov 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (HK$37.3m market cap, or US$4.79m). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Revenue is less than US$5m (HK$19m revenue, or US$2.5m). Reported Earnings • Nov 27
First half 2025 earnings released: HK$0.026 loss per share (vs HK$0.011 loss in 1H 2024) First half 2025 results: HK$0.026 loss per share (further deteriorated from HK$0.011 loss in 1H 2024). Revenue: HK$7.30m (down 55% from 1H 2024). Net loss: HK$5.50m (loss widened 143% from 1H 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Announcement • Nov 08
Hephaestus Holdings Limited to Report First Half, 2025 Results on Nov 22, 2024 Hephaestus Holdings Limited announced that they will report first half, 2025 results on Nov 22, 2024 New Risk • Sep 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 9.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.2% average weekly change). Revenue is less than US$5m (HK$28m revenue, or US$3.6m). Market cap is less than US$100m (HK$81.8m market cap, or US$10.5m). New Risk • Sep 04
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: HK$68.9m (US$8.84m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (HK$68.9m market cap, or US$8.84m). Minor Risk Revenue is less than US$5m (HK$28m revenue, or US$3.6m). Announcement • Sep 02
Hephaestus Holdings Limited, Annual General Meeting, Sep 26, 2024 Hephaestus Holdings Limited, Annual General Meeting, Sep 26, 2024, at 14:30 China Standard Time. Location: room 402a, 4/f, park commercial centre, 180 tung lo wan road, causeway bay., Hong Kong Reported Earnings • Jul 30
Full year 2024 earnings released: HK$0.04 loss per share (vs HK$0.014 loss in FY 2023) Full year 2024 results: HK$0.04 loss per share (further deteriorated from HK$0.014 loss in FY 2023). Revenue: HK$28.0m (down 21% from FY 2023). Net loss: HK$8.56m (loss widened 180% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 137 percentage points per year, which is a significant difference in performance. Reported Earnings • Jun 29
Full year 2024 earnings released: HK$0.04 loss per share (vs HK$0.014 loss in FY 2023) Full year 2024 results: HK$0.04 loss per share (further deteriorated from HK$0.014 loss in FY 2023). Revenue: HK$28.0m (down 21% from FY 2023). Net loss: HK$8.55m (loss widened 180% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 115 percentage points per year, which is a significant difference in performance. Announcement • Jun 14
Hephaestus Holdings Limited to Report Fiscal Year 2024 Results on Jun 27, 2024 Hephaestus Holdings Limited announced that they will report fiscal year 2024 results on Jun 27, 2024 New Risk • May 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Market cap is less than US$10m (HK$76.4m market cap, or US$9.79m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Revenue is less than US$5m (HK$33m revenue, or US$4.3m). New Risk • Apr 12
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: HK$77.5m (US$9.89m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (HK$77.5m market cap, or US$9.89m). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Revenue is less than US$5m (HK$33m revenue, or US$4.3m). New Risk • Apr 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Revenue is less than US$5m (HK$33m revenue, or US$4.3m). Market cap is less than US$100m (HK$104.4m market cap, or US$13.3m). Reported Earnings • Nov 15
Second quarter 2024 earnings released: HK$0.006 loss per share (vs HK$0.013 loss in 2Q 2023) Second quarter 2024 results: HK$0.006 loss per share (improved from HK$0.013 loss in 2Q 2023). Revenue: HK$6.75m (down 1.0% from 2Q 2023). Net loss: HK$1.32m (loss narrowed 53% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Oct 28
Hephaestus Holdings Limited to Report First Half, 2024 Results on Nov 10, 2023 Hephaestus Holdings Limited announced that they will report first half, 2024 results on Nov 10, 2023 Announcement • Aug 24
Hephaestus Holdings Limited, Annual General Meeting, Sep 22, 2023 Hephaestus Holdings Limited, Annual General Meeting, Sep 22, 2023, at 14:30 China Standard Time. Location: Room 402A, 4/F, Park Commercial Centre, 180 Tung Lo Wan Road, Causeway Bay Hong Kong Agenda: To receive, consider and adopt the audited consolidated financial statements of the Company and its subsidiaries and the reports of the directors (the "Director(s)") and auditor of the Company for the year ended 31 March 2023; to re-elect Mr. Huang Liang as executive Director; to re-elect Ms. Yip Hiu Ying as executive Director; to re-elect Mr. Tang Chin Ting as independent non-executive Director; to re-elect Ms. Tong Yuk Ying Yannie as independent non-executive Director; to authorise the board of Directors to fix the Directors' remuneration; to re-appoint LIF & Wong CPA Limited as the auditors of the Company and to authorise the board of Directors to fix their remuneration; and to discuss other matters. Reported Earnings • Aug 13
First quarter 2024 earnings released: HK$0.004 loss per share (vs HK$0.005 profit in 1Q 2023) First quarter 2024 results: HK$0.004 loss per share (down from HK$0.005 profit in 1Q 2023). Revenue: HK$9.32m (down 18% from 1Q 2023). Net loss: HK$943.0k (down 193% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Announcement • Aug 01
Hephaestus Holdings Limited Announces Company Secretary Changes The board of directors of Hephaestus Holdings Limited announced that, with effect from 31 July 2023, Ms. Chan Yuen Mui has resigned as the company secretary of the Company. The Board announced that Ms. Cheng Pui Ling has been appointed as the Company Secretary, an Authorised Representative and the Process Agent in replacement of Ms. Chan with effect from 31 July 2023. Ms. Cheng has over 7 years of all-round experience in administrative and company secretarial fields. She is an associate member of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute in the United Kingdom. Ms. Cheng holds a Master of Corporate Governance degree from Hong Kong Metropolitan University and a Bachelor of Laws Degree from Jinan University. Announcement • Jul 29
Hephaestus Holdings Limited to Report Q1, 2024 Results on Aug 11, 2023 Hephaestus Holdings Limited announced that they will report Q1, 2024 results on Aug 11, 2023 New Risk • Jun 26
New minor risk - Revenue size The company makes less than US$5m in revenue. Total revenue: HK$35m (US$4.5m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Revenue is less than US$5m (HK$35m revenue, or US$4.5m). Market cap is less than US$100m (HK$94.8m market cap, or US$12.1m). Reported Earnings • Jun 25
Full year 2023 earnings released: HK$0.014 loss per share (vs HK$0.019 profit in FY 2022) Full year 2023 results: HK$0.014 loss per share (down from HK$0.019 profit in FY 2022). Revenue: HK$35.5m (down 31% from FY 2022). Net loss: HK$3.05m (down 174% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Announcement • Jun 09
Hephaestus Holdings Limited to Report Fiscal Year 2023 Results on Jun 23, 2023 Hephaestus Holdings Limited announced that they will report fiscal year 2023 results on Jun 23, 2023 Announcement • May 26
Hephaestus Holdings Limited Announces Board Changes Hephaestus Holdings Limited announced the resignation of Ms. Lou Yi as an executive director of the Company. As disclosed in the Announcement, Ms. Lou has resigned as an executive director of the Company with effect from 24 May 2023. The Board announced that, following the resignation of Ms. Lou, Ms. Yip Hiu Ying, an executive director of the Company, has been appointed as an Authorised Representative of the Company in place of Ms. Lou with effect from 24 May 2023. Board Change • Mar 01
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Director Yuqiang Zheng is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Feb 10
Third quarter 2023 earnings released: HK$0.003 loss per share (vs HK$0 in 3Q 2022) Third quarter 2023 results: HK$0.003 loss per share (further deteriorated from HK$0 in 3Q 2022). Revenue: HK$8.13m (down 36% from 3Q 2022). Net loss: HK$660.0k (down HK$751.0k from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Announcement • Jan 31
Hephaestus Holdings Limited to Report Nine Months, 2023 Results on Feb 09, 2023 Hephaestus Holdings Limited announced that they will report nine months, 2023 results on Feb 09, 2023 Announcement • Nov 16
Hephaestus Holdings Limited Announces Executive Changes The board of directors of Hephaestus Holdings Limited announced that, with effect from 15 November 2022, Ms. Kwong Oi Man Patty has resigned as the company secretary of the Company, an authorised representative of the Company under Rule 5.24 of the Rules Governing the Listing of Securities on GEM of The Stock Exchange of Hong Kong Limited and the authorised representative to accept service of process or notice on behalf of the Company in Hong Kong (the Process Agent) under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong). The Board announced that Ms. Chan Yuen Mui has been appointed as the Company Secretary, an Authorised Representative and the Process Agent in replacement of Ms. Kwong with effect from 15 November 2022. Ms. Chan has over 15 years of experience in commercial administration and corporate secretarial fields. Ms. Chan is currently the assistant manager of a corporate advisory firm in Hong Kong. She is an associate member of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute in the United Kingdom. Ms. Chan obtained an Honours Bachelor of Business Administration degree from Hong Kong Baptist University and a Master of Corporate Governance degree from The Hong Kong Polytechnic University. Ms. Chan served as the company secretary of Gemilang International Limited, from May 2019 to December 2020. Board Change • Nov 16
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Director Yuqiang Zheng is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Nov 02
Hephaestus Holdings Limited to Report First Half, 2023 Results on Nov 11, 2022 Hephaestus Holdings Limited announced that they will report first half, 2023 results on Nov 11, 2022 Announcement • Aug 27
Hephaestus Holdings Limited, Annual General Meeting, Sep 30, 2022 Hephaestus Holdings Limited, Annual General Meeting, Sep 30, 2022, at 11:00 China Standard Time. Location: Cre8 (Greater China) Ltd., 29 Queen's Road Central Hong Kong New Territories Hong Kong Agenda: To receive, consider and adopt the audited consolidated financial statements of the Company and its subsidiaries and the reports of the directors and auditor of the Company for the year ended 31 March 2022; to re-appoint RSM Hong Kong as the auditors of the Company and to authorize the board of Directors to fix their remuneration; and to consider and, if thought fit, pass the following resolution as ordinary resolution; and other. Reported Earnings • Aug 14
First quarter 2023 earnings released: EPS: HK$0.005 (vs HK$0.008 in 1Q 2022) First quarter 2023 results: EPS: HK$0.005 (down from HK$0.008 in 1Q 2022). Revenue: HK$11.3m (down 19% from 1Q 2022). Net income: HK$1.02m (down 50% from 1Q 2022). Profit margin: 9.0% (down from 14% in 1Q 2022). The decrease in margin was driven by lower revenue. Announcement • Aug 03
Hephaestus Holdings Limited to Report Q1, 2023 Results on Aug 12, 2022 Hephaestus Holdings Limited announced that they will report Q1, 2023 results on Aug 12, 2022 Reported Earnings • Jun 29
Full year 2022 earnings released: EPS: HK$0.019 (vs HK$0.034 in FY 2021) Full year 2022 results: EPS: HK$0.019 (down from HK$0.034 in FY 2021). Revenue: HK$51.7m (down 2.8% from FY 2021). Net income: HK$4.15m (down 50% from FY 2021). Profit margin: 8.0% (down from 15% in FY 2021). The decrease in margin was primarily driven by higher expenses. Announcement • Jun 29
Hephaestus Holdings Limited, Annual General Meeting, Sep 15, 2022 Hephaestus Holdings Limited, Annual General Meeting, Sep 15, 2022. Announcement • Jun 14
Hephaestus Holdings Limited to Report Fiscal Year 2022 Results on Jun 28, 2022 Hephaestus Holdings Limited announced that they will report fiscal year 2022 results on Jun 28, 2022 Buying Opportunity • Jun 13
Now 27% undervalued Over the last 90 days, the stock is up 48%. The fair value is estimated to be HK$1.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 14%. Buying Opportunity • May 24
Now 24% undervalued Over the last 90 days, the stock is up 56%. The fair value is estimated to be HK$1.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Earnings per share has declined by 14%. Board Change • Apr 27
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Non-Executive Director Yuqiang Zheng is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Feb 11
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: HK$0 (down from HK$0.002 in 3Q 2021). Revenue: HK$12.6m (up 17% from 3Q 2021). Net income: HK$91.0k (down 83% from 3Q 2021). Profit margin: 0.7% (down from 5.0% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst estimates. Announcement • Jan 20
Ye Huacong completed the acquisition of 1.91% stake in Hephaestus Holdings Limited (SEHK:8173) for HKD 1.9 million. Ye Huacong made an offer to acquire remaining 26.18% stake in Hephaestus Holdings Limited (SEHK:8173) for HKD 26.19 million on November 26, 2021. Under the terms, consideration is set as HKD 0.4644 per share. In a related transaction Ye Huacong acquired 73.81% stake in Hephaestus Holdings Limited (SEHK:8173) from Whistle Up Limited for HKD 73.8 million on November 26, 2021. The Offeror intends to finance the entire consideration payable under the Offer by the Loan Facility granted to it by Kingston Securities.
Offer is unconditional in all aspects when it is made and is not conditional upon acceptances being received in respect of a minimum number of Shares. Transaction is expected to close on January 18, 2022. Kingston Corporate Finance acted as the financial advisor to Ye. Trinity Corporate Finance Limited acted as financial advisor to directors of Hephaestus Holdings Limited. Merdeka Corporate Finance Limited acted as financial advisor to Hephaestus Holdings Limited. Union Registrars Limited acted as registrar in the transaction.
Ye Huacong completed the acquisition of 1.91% stake in Hephaestus Holdings Limited (SEHK:8173) for HKD 1.9 million on January 18, 2022. Valid acceptances had been received in respect of a total of 4,121,271 Offer Shares. Upon Completion and immediately prior to commencement of the Offer Period, the Offeror and parties acting in concert with it were interested in a total of 158,947,368 Shares, representing approximately 73.81% and immediately after the close of the Offer, the Offeror and parties acting in concert with it were interested in a total of 163,068,639 Shares, representing approximately 75.72% of Hephaestus Holdings Limited. Reported Earnings • Nov 12
Second quarter 2022 earnings released: EPS HK$0.001 (vs HK$0.009 in 2Q 2021) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: HK$11.7m (down 5.5% from 2Q 2021). Net income: HK$145.0k (down 93% from 2Q 2021). Profit margin: 1.2% (down from 18% in 2Q 2021). Reported Earnings • Aug 10
First quarter 2022 earnings released: EPS HK$0.002 (vs HK$0.003 in 1Q 2021) The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2022 results: Revenue: HK$13.9m (down 13% from 1Q 2021). Net income: HK$2.02m (down 44% from 1Q 2021). Profit margin: 14% (down from 23% in 1Q 2021). Reported Earnings • Jun 26
Full year 2021 earnings released: EPS HK$0.007 (vs HK$0.046 loss in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: HK$53.2m (down 27% from FY 2020). Net income: HK$8.21m (up HK$50.9m from FY 2020). Profit margin: 15% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Announcement • Jan 27
Union Asia Enterprise Holdings Limited to Report Nine Months, 2021 Results on Feb 05, 2021 Union Asia Enterprise Holdings Limited announced that they will report nine months, 2021 results on Feb 05, 2021 Reported Earnings • Nov 12
Second quarter 2021 earnings released: EPS HK$0.002 The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: HK$12.4m (down 48% from 2Q 2020). Net income: HK$2.17m (down 91% from 2Q 2020). Profit margin: 18% (down from 104% in 2Q 2020). The decrease in margin was driven by lower expenses. Announcement • Oct 29
Union Asia Enterprise Holdings Limited to Report Q2, 2021 Results on Nov 09, 2020 Union Asia Enterprise Holdings Limited announced that they will report Q2, 2021 results on Nov 09, 2020 Announcement • Jul 31
Union Asia Enterprise Holdings Limited to Report Q1, 2021 Results on Aug 07, 2020 Union Asia Enterprise Holdings Limited announced that they will report Q1, 2021 results on Aug 07, 2020 
